Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches

TB Emran, A Shahriar, AR Mahmud, T Rahman… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the leading causes of death worldwide. Several treatments are available for
cancer treatment, but many treatment methods are ineffective against multidrug-resistant …

The platelet lifeline to cancer: challenges and opportunities

M Haemmerle, RL Stone, DG Menter… - Cancer cell, 2018 - cell.com
Besides their function in limiting blood loss and promoting wound healing, experimental
evidence has highlighted platelets as active players in all steps of tumorigenesis including …

Benchmarking blood collection tubes and processing intervals for extracellular vesicle performance metrics

B Dhondt, C Pinheiro, E Geeurickx… - Journal of …, 2023 - Wiley Online Library
The analysis of extracellular vesicles (EV) in blood samples is under intense investigation
and holds the potential to deliver clinically meaningful biomarkers for health and disease …

New fundamentals in hemostasis

HH Versteeg, JWM Heemskerk, M Levi… - Physiological …, 2013 - journals.physiology.org
Hemostasis encompasses the tightly regulated processes of blood clotting, platelet
activation, and vascular repair. After wounding, the hemostatic system engages a plethora of …

Contribution of platelets to tumour metastasis

LJ Gay, B Felding-Habermann - Nature Reviews Cancer, 2011 - nature.com
Extensive experimental evidence shows that platelets support tumour metastasis. The
activation of platelets and the coagulation system have a crucial role in the progression of …

Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy?

R Callaghan, F Luk, M Bebawy - Drug Metabolism and Disposition, 2014 - ASPET
P-glycoprotein (P-gp) is a key player in the multidrug-resistant phenotype in cancer. The
protein confers resistance by mediating the ATP-dependent efflux of an astonishing array of …

Haemostasis in chronic kidney disease

J Lutz, J Menke, D Sollinger, H Schinzel… - Nephrology Dialysis …, 2014 - academic.oup.com
The coagulation system has gained much interest again as new anticoagulatory substances
have been introduced into clinical practice. Especially patients with renal failure are likely …

Platelets at work in primary hemostasis

K Broos, HB Feys, SF De Meyer, K Vanhoorelbeke… - Blood reviews, 2011 - Elsevier
When platelet numbers are low or when their function is disabled, the risk of bleeding is
high, which on the one hand indicates that in normal life vascular damage is a rather …

Cellular mechanisms underlying the formation of circulating microparticles

O Morel, L Jesel, JM Freyssinet… - … , thrombosis, and vascular …, 2011 - Am Heart Assoc
Microparticles (MPs) derived from platelets, monocytes, endothelial cells, red blood cells,
and granulocytes may be detected in low concentrations in normal plasma and at increased …

Placenta‐derived exosomes and syncytiotrophoblast microparticles and their role in human reproduction: immune modulation for pregnancy success

L Mincheva‐Nilsson, V Baranov - American journal of …, 2014 - Wiley Online Library
The syncytiotrophoblast (STB) of human placenta constitutively produces and secretes
extracellular vesicles of different size, morphology and function that enter the maternal …